Latest News

Healthcare giant Johnson & Johnson (J&J) has been given a little bit of breathing room in the Missouri baby powder cancer litigation. According to a recent order from a judge overseeing the proceedings, the next baby powder trial will be pushed back five months.

Blood thinners are a common treatment for patients suffering from conditions like deep vein thrombosis (DVT), atrial fibrillation (AFib), or for patients who are at an increased risk of suffering strokes from blood clots. A new study from the Intermountain Medical Center Heart Institute found AFib patients taking blood thinners are at an increased risk of developing dementia.

After publishing a new, updated label for the Essure contraceptive device and a patient’s checklist to describe risks and benefits, the U.S. Food and Drug Administration officially closed its investigation of a trade complaint lodged against the device’s manufacturers. While the FDA’s investigation might be over, the fight over the Essure contraceptive is far from over.

When the U.S. Food and Drug Administration released a statement in 2014 discouraging the use of power morcellators to remove uterine fibroids, many considered this the end of morcellator use. Morcellator manufacturers like Ethicon Inc., a subsidiary of Johnson & Johnson (J&J), suspended sales; and, the last few years have seen morcellator use drastically decline. One device manufacturer hopes to shake off the morcellator’s bad reputation with a new product, but there’s no guarantee it is any safer.

Heartburn is a painful condition that could cause the development of cancer if left untreated for a long period of time, but mounting studies suggest drugs meant to treat these symptoms present risks of their own. A new study of almost 245,000 adults found a significant increase in stroke risks in patients taking high doses of heartburn drugs versus patients taking lower doses or no drugs at all.

Popular heartburn drugs like Nexium and Prilosec allegedly caused kidney injuries in thousands of Americans. The U.S. Judicial Panel on Multidistrict Litigation (JMPL) is currently reviewing the defendants’ response to plaintiffs’ motion to consolidate proton pump inhibitor (PPI) side effects claims. The decision whether or not to create a multidistrict litigation (MDL) will be a heavy one because plaintiffs’ attorneys claim they are currently investigating thousands of claims.

With the recent release of the FDA’s revised checklist and label update for the Essure contraceptive device, many women are revamping their efforts to get the device removed from the market. Thousands of women harmed by the device believe it is unreasonably dangerous and that the FDA isn’t taking sufficient action to keep patients safe.

When the third Pinnacle hip implant trial began in early October, the jury might not have imagined the case would be as complex as it is. The stakes are high for both sides as they enter in to the sixth week of proceedings.

A Texas woman joins nearly 1,000 other patients in their fight to hold Cook Medical responsible for producing defective IVC filters. The woman had a Cook Celect IVC filter implanted in November 2009 and suffered severe complications from the device.

Diane Shannon underwent surgery in a Chicago hospital and ended up with unusual and very serious injuries. Ms. Shannon filed a lawsuit alleging a Bair Hugger warming blanket caused her to suffer burn injuries all over her body.